{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:23:16Z","timestamp":1787026996486,"version":"build-2736575974"},"reference-count":87,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Type 2 diabetes, one of the most common noncommunicable diseases, is a metabolic disorder that results in failed homeostatic control in several body systems, including hepatic function. Due to the gut microbiome\u2019s potential role in diabetes\u2019 pathogenesis, prebiotics, probiotics, and synbiotics have been proposed as complimentary therapeutic approaches aimed at microbiota readjustment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review was conducted on PubMed, Scopus, Web of Science, Embase, and the Cochrane Library examining the effect of probiotics, prebiotics, and synbiotics on hepatic biomarkers in patients with diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      From 9,502 search hits, 10 studies met the inclusion criteria and were included in this review. A total of 816 participants (460 intervention and 356 control) were investigated for the effects of nine different hepatic biomarker measurements including aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, total protein, bilirubin, liver steatosis, liver stiffness, fatty liver index, and gamma-glutamyl transferase levels. Of the 13 intervention groups analyzed from the 10 studies, 3 were prebiotic interventions, 3 were single species probiotic interventions, 3 were multi-species probiotic interventions, and 4 were synbiotic interventions. Nutraceuticals used in these trials included six genera of bacteria (\n                      <jats:italic>Lactobacillus, Bifidobacterium, Streptococcus, Acetobacter, Lactococcus<\/jats:italic>\n                      , and\n                      <jats:italic>Propionibacterium<\/jats:italic>\n                      ), five different prebiotic formulations (inulin, inulin and beta carotene, chicory inulin enriched with oligofructose, galacto-oligosaccharides syrup, and powdered cinnamon), or a combination of these to form multi-species probiotics or synbiotics.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although some studies showed insignificant changes in hepatic biomarkers, generally the results yielded a decrease in liver damage due to reduced oxidative stress, pro-inflammatory cytokines, gut dysbiosis, and insulin resistance which led to improvements in hepatic biomarker levels.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2022.1052619","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T01:55:36Z","timestamp":1669859736000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Can probiotic, prebiotic, and synbiotic supplementation modulate the gut-liver axis in type 2 diabetes? A narrative and systematic review of clinical trials"],"prefix":"10.3389","volume":"9","author":[{"given":"Yousef","family":"Al-Najjar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Arabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradipta","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Chaari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/J.DIABRES.2021.109119","article-title":"IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0194127","article-title":"Risk factors for type 2 diabetes mellitus: an exposure-wide umbrella review of meta-analyses.","volume":"13","author":"Bellou","year":"2018","journal-title":"PLoS One."},{"key":"B3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of type 2 diabetes-global burden of disease and forecasted trends.","volume":"10","author":"Abdul","year":"2019","journal-title":"J Epidemiol Glob Health."},{"key":"B4","year":"2022","journal-title":"The Cost of Diabetes."},{"key":"B5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2337\/DC14-2441","article-title":"Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American diabetes association and the European association for the study of diabetes.","volume":"38","author":"Inzucchi","year":"2015","journal-title":"Diabetes Care."},{"key":"B6","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/J.AMJMED.2017.04.004","article-title":"Pharmacologic management of type 2 diabetes mellitus: available therapies.","volume":"130","author":"Thrasher","year":"2017","journal-title":"Am J Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1080\/10408398.2018.1547268","article-title":"Using probiotics for type 2 diabetes mellitus intervention: advances, questions, and potential.","volume":"60","author":"Sun","year":"2019","journal-title":"Crit Rev Food Sci Nutr."},{"key":"B8","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.clnesp.2022.04.002","article-title":"Impact of probiotic supplementation in a patient with type 2 diabetes on glycemic and lipid profile.","volume":"49","author":"Ziegler","year":"2022","journal-title":"Clin Nutr ESPEN."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-018-0353-2","article-title":"The effects of probiotic supplementation on metabolic status in type 2 diabetic patients with coronary heart disease.","volume":"10","author":"Raygan","year":"2018","journal-title":"Diabetol Metab Syndr."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/J.PHRS.2022.106520","article-title":"The effect of microbiome-modulating probiotics, prebiotics and synbiotics on glucose homeostasis in type 2 diabetes: a systematic review, meta-analysis, and meta-regression of clinical trials.","volume":"185","author":"Paul","year":"2022","journal-title":"Pharmacol Res."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12535-9","article-title":"Probiotic reduces bacterial translocation in type 2 diabetes mellitus: a randomised controlled study.","volume":"7","author":"Sato","year":"2017","journal-title":"Sci Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/0966-842X(96)10057-3","article-title":"The indigenous gastrointestinal microflora.","volume":"4","author":"Berg","year":"1996","journal-title":"Trends Microbiol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8010008","article-title":"The gut microbiome and type 2 diabetes mellitus: discussing a complex relationship.","volume":"8","author":"Sikalidis","year":"2020","journal-title":"Biomedicines."},{"key":"B14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/ANNUREV.NUTR.22.011602.092259","article-title":"How host-microbial interactions shape the nutrient environment of the mammalian intestine.","volume":"22","author":"Hooper","year":"2002","journal-title":"Annu Rev Nutr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/AJCN\/32.1.149","article-title":"Introduction to metabolic activities of intestinal bacteria.","volume":"32","author":"Smith","year":"1979","journal-title":"Am J Clin Nutr."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/J.BIOPHA.2021.111817","article-title":"Immunomodulatory roles of microbiota-derived short-chain fatty acids in bacterial infections.","volume":"141","author":"Ranjbar","year":"2021","journal-title":"Biomed Pharmacother."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00025","article-title":"The role of short-chain fatty acids from gut microbiota in gut-brain communication.","volume":"11","author":"Silva","year":"2020","journal-title":"Front Endocrinol (Lausanne)."},{"key":"B18","doi-asserted-by":"publisher","first-page":"17737","DOI":"10.3748\/wjg.v20.i47.17737","article-title":"Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective.","volume":"20","author":"Han","year":"2014","journal-title":"World J Gastroenterol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/FCIMB.2020.595759","article-title":"The role of intestinal bacteria and gut\u2013brain axis in hepatic encephalopathy.","volume":"10","author":"Chen","year":"2020","journal-title":"Front Cell Infect Microbiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/nature05414","article-title":"An obesity-associated gut microbiome with increased capacity for energy harvest.","volume":"444","author":"Turnbaugh","year":"2006","journal-title":"Nature."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/FNUT.2022.906243","article-title":"The promising role of microbiome therapy on biomarkers of inflammation and oxidative stress in type 2 diabetes: a systematic and narrative review.","volume":"9","author":"Paul","year":"2022","journal-title":"Front Nutr."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-81303-1_49-1","article-title":"Markers of bacterial translocation in type 2 diabetes mellitus.","author":"Meheissen","year":"2022","journal-title":"Biomarkers in Diabetes. Biomarkers in Disease: Methods, Discoveries and Applications."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/J.LFS.2022.120760","article-title":"Role of gut bacterial and non-bacterial microbiota in alcohol-associated liver disease: molecular mechanisms, biomarkers, and therapeutic prospective.","volume":"305","author":"Zafari","year":"2022","journal-title":"Life Sci."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.15252\/EMMM.201809302","article-title":"The role of the microbiome in NAFLD and NASH.","volume":"11","author":"Kolodziejczyk","year":"2019","journal-title":"EMBO Mol Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1136\/PGMJ.56.661.767","article-title":"Liver disease in patients with diabetes mellitus.","volume":"56","author":"Foster","year":"1980","journal-title":"Postgrad Med J."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/S13098-019-0409-Y\/TABLES\/2","article-title":"Reduced plasma albumin predicts type 2 diabetes and is associated with greater adipose tissue macrophage content and activation.","volume":"11","author":"Chang","year":"2019","journal-title":"Diabetol Metab Syndr."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.18295\/SQUMJ.2016.16.02.002","article-title":"Mechanisms of diabetes-induced liver damage: the role of oxidative stress and inflammation.","volume":"16","author":"Mohamed","year":"2016","journal-title":"Sultan Qaboos Univ Med J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1079\/9781845937980.0024","article-title":"Aminotransferases.","author":"Vroon","year":"1990","journal-title":"Amino Acids in Human Nutrition and Health."},{"key":"B29","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(72)90487-4","article-title":"Serum-transaminase activities in liver disease.","volume":"1","author":"De Ritis","year":"1972","journal-title":"Lancet (London England)."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/S12902-019-0437-5\/TABLES\/4","article-title":"Elevated serum levels of aminotransferases in relation to unhealthy foods intake: tehran lipid and glucose study.","volume":"19","author":"Mirmiran","year":"2019","journal-title":"BMC Endocr Disord."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.17179\/EXCLI2016-800","article-title":"The past and present of serum aminotransferases and the future of liver injury biomarkers.","volume":"15","author":"McGill","year":"2016","journal-title":"EXCLI J."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04631-7","article-title":"Liver fat, hepatic enzymes, alkaline phosphatase and the risk of incident type 2 diabetes: a prospective study of 132,377 adults.","volume":"7","author":"Chen","year":"2017","journal-title":"Sci Rep."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3803\/ENM.2013.28.1.26","article-title":"Association between serum albumin, insulin resistance, and incident diabetes in nondiabetic subjects.","volume":"28","author":"Bae","year":"2013","journal-title":"Endocrinol Metab."},{"key":"B34","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/J.1478-3231.2008.01716.X","article-title":"Bilirubin in clinical practice: a review.","volume":"28","author":"Fevery","year":"2008","journal-title":"Liver Int."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.2337\/DB14-0691","article-title":"Bilirubin: a potential biomarker and therapeutic target for diabetic nephropathy.","volume":"63","author":"Hull","year":"2014","journal-title":"Diabetes."},{"key":"B36","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1161\/01.ATV.16.2.250","article-title":"Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease.","volume":"16","author":"Hopkins","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1126\/SCIENCE.3029864","article-title":"Bilirubin is an antioxidant of possible physiological importance.","volume":"235","author":"Stocker","year":"1987","journal-title":"Science."},{"key":"B38","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/ncpendmet0190","article-title":"Mechanisms of disease: hepatic steatosis in type 2 diabetes\u2014pathogenesis and clinical relevance.","volume":"2","author":"Roden","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab."},{"key":"B39","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1126\/science.1104343","article-title":"Mitochondrial dysfunction and type 2 diabetes.","volume":"307","author":"Lowell","year":"2005","journal-title":"Science."},{"key":"B40","year":"2022","journal-title":"Gamma-Glutamyl Transpeptidase \u2013 An Overview."},{"key":"B41","first-page":"123","article-title":"Relationship between gamma-glutamyl transferase and glucose intolerance in first degree relatives of type 2 diabetics patients.","volume":"16","author":"Haghighi","year":"2011","journal-title":"J Res Med Sci."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2021.632335\/BIBTEX","article-title":"Modulating the microbiota as a therapeutic intervention for type 2 diabetes.","volume":"12","author":"Huda","year":"2021","journal-title":"Front Endocrinol (Lausanne)."},{"key":"B43","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic.","volume":"11","author":"Hill","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41575-020-0344-2","article-title":"The international scientific association for probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics.","volume":"17","author":"Swanson","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/MOLECULES26196076","article-title":"Probiotics regulate gut microbiota: an effective method to improve immunity.","volume":"26","author":"Wang","year":"2021","journal-title":"Molecules."},{"key":"B46","first-page":"51","year":"2005","journal-title":"Cochrane Handb Syst Rev"},{"key":"B47","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/DOM.12861","article-title":"Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: a randomized controlled trial.","volume":"19","author":"Mobini","year":"2017","journal-title":"Diabetes Obes Metab."},{"key":"B48","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1080\/07315724.2015.1032443","article-title":"The consumption of synbiotic bread containing Lactobacillus sporogenes and inulin affects nitric oxide and malondialdehyde in patients with type 2 diabetes mellitus: randomized, double-blind, placebo-controlled trial.","volume":"35","author":"Bahmani","year":"2015","journal-title":"J Am Coll Nutr."},{"key":"B49","doi-asserted-by":"publisher","first-page":"205","DOI":"10.5603\/DK.2019.0016","article-title":"Probiotics and smectite absorbent gel formulation reduce liver stiffness, transaminase and cytokine levels in NAFLD associated with type 2 diabetes: a randomized clinical study.","volume":"8","author":"Kobyliak","year":"2019","journal-title":"Clin Diabetol."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1186\/S12906-015-0952-5\/FIGURES\/4","article-title":"Effect of microbial cell preparation on renal profile and liver function among type 2 diabetics: a randomized controlled trial.","volume":"15","author":"Firouzi","year":"2015","journal-title":"BMC Complement Altern Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/S13410-013-0187-2\/TABLES\/3","article-title":"Effect of multispecies probiotic supplements on serum minerals, liver enzymes and blood pressure in patients with type 2 diabetes.","volume":"35","author":"Asemi","year":"2015","journal-title":"Int J Diabetes Dev Ctries."},{"key":"B52","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pcd.2015.10.009","article-title":"The effect of enriched chicory inulin on liver enzymes, calcium homeostasis and hematological parameters in patients with type 2 diabetes mellitus: a randomized placebo-controlled trial.","volume":"10","author":"Farhangi","year":"2016","journal-title":"Prim Care Diabetes."},{"key":"B53","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3920\/BM2016.0230","article-title":"Galacto-oligosaccharides ameliorate dysbiotic Bifidobacteriaceae decline in Japanese patients with type 2 diabetes.","volume":"8","author":"Gonai","year":"2017","journal-title":"Benef Microbes."},{"key":"B54","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.clnu.2015.07.009","article-title":"Effects of beta-carotene fortified synbiotic food on metabolic control of patients with type 2 diabetes mellitus: a double-blind randomized cross-over controlled clinical trial.","volume":"35","author":"Asemi","year":"2015","journal-title":"Clin Nutr."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.4103\/ijpvm.IJPVM_257_16","article-title":"Effects of synbiotic food consumption on serum minerals, liver enzymes, and blood pressure in patients with type 2 diabetes: a double-blind randomized cross-over controlled clinical trial.","volume":"8","author":"Asemi","year":"2017","journal-title":"Int J Prev Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/S40200-019-00474-3","article-title":"Effects of probiotic, cinnamon, and synbiotic supplementation on glycemic control and antioxidant status in people with type 2 diabetes; a randomized, double-blind, placebo-controlled study.","volume":"19","author":"Mirmiranpour","year":"2019","journal-title":"J Diabetes Metab Disord."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.cell.2018.02.044","article-title":"The human gut microbiome: from association to modulation.","volume":"172","author":"Schmidt","year":"2018","journal-title":"Cell."},{"key":"B58","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1179\/JOC.2009.21.4.371","article-title":"Should Lactobacillus sporogenes and Bacillus coagulans have a future?","volume":"21","author":"Drago","year":"2013","journal-title":"J Chemother."},{"key":"B59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/(SICI)1521-4028(199903)39:1<3::AID-JOBM3>3.0.CO;2-O","article-title":"Occurrence of selected bacterial groups in the faeces of piglets fed with Bacillus coagulans as probiotic.","volume":"39","author":"Adami","year":"1999","journal-title":"J Basic Microbiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/J.NUMECD.2005.05.003","article-title":"A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress.","volume":"15","author":"Del Rio","year":"2005","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.22038\/IJBMS.2019.32936.7866","article-title":"The impact of Lactobacillus acidophilus on hepatic and colonic fibrosis induced by ethephon in a rat model.","volume":"22","author":"Bahr","year":"2019","journal-title":"Iran J Basic Med Sci."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00384-21","article-title":"Lactobacillus acidophilus LA14 alleviates liver injury.","volume":"6","author":"Lv","year":"2021","journal-title":"mSystems."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10020288","article-title":"The Lactobacillus as a probiotic: focusing on liver diseases.","volume":"10","author":"Jeong","year":"2022","journal-title":"Microorganisms."},{"key":"B64","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.1039\/C9FO01062A","article-title":"Lactobacillus acidophilus alleviates type 2 diabetes by regulating hepatic glucose, lipid metabolism and gut microbiota in mice.","volume":"10","author":"Yan","year":"2019","journal-title":"Food Funct."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6793-8-19","article-title":"Butyrate ingestion improves hepatic glycogen storage in the re-fed rat.","volume":"8","author":"Beauvieux","year":"2008","journal-title":"BMC Physiol."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3390\/BIOLOGY10040322","article-title":"Multi-strain probiotics: synergy among isolates enhances biological activities.","volume":"10","author":"Kwoji","year":"2021","journal-title":"Biology (Basel)."},{"key":"B67","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/B978-0-12-803620-4.00014-1","article-title":"Clinical pathology.","author":"York","year":"2017","journal-title":"A Comprehensive Guide to Toxicology in Nonclinical Drug Development."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.5114\/AOMS.2016.62150","article-title":"Bifidobacteria and Lactobacilli in the gut microbiome of children with non-alcoholic fatty liver disease: which strains act as health players?","volume":"14","author":"Putignani","year":"2018","journal-title":"Arch Med Sci."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002658","article-title":"Clinical uses of probiotics.","volume":"95","author":"Islam","year":"2016","journal-title":"Medicine (Baltimore)."},{"key":"B70","doi-asserted-by":"publisher","first-page":"S139","DOI":"10.1079\/BJN\/2002529","article-title":"Functional foods: concepts and application to inulin and oligofructose.","volume":"87","author":"Roberfroid","year":"2002","journal-title":"Br J Nutr."},{"key":"B71","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1017\/S0007114510003363","article-title":"Prebiotic effects: metabolic and health benefits.","volume":"104","author":"Roberfroid","year":"2010","journal-title":"Br J Nutr."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/sj.ejcn.1602636","article-title":"A double-blind placebo-controlled study to establish the bifidogenic dose of inulin in healthy humans.","volume":"61","author":"Kolida","year":"2007","journal-title":"Eur J Clin Nutr."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/J.CELL.2010.05.005","article-title":"Specificity of polysaccharide use in intestinal Bacteroides species determines diet-induced microbiota alterations.","volume":"141","author":"Sonnenburg","year":"2010","journal-title":"Cell."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/FNUT.2020.563605\/BIBTEX","article-title":"Epigenetic effects of gut metabolites: exploring the path of dietary prevention of type 1 diabetes.","volume":"7","author":"Al Theyab","year":"2020","journal-title":"Front Nutr."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1186\/S13063-016-1486-Y\/TABLES\/2","article-title":"Effect of prebiotic intake on gut microbiota, intestinal permeability and glycemic control in children with type 1 diabetes: study protocol for a randomized controlled trial.","volume":"17","author":"Ho","year":"2016","journal-title":"Trials."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/4441022a","article-title":"Human gut microbes associated with obesity.","volume":"444","author":"Ciofi","year":"2006","journal-title":"Nature."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS20020438","article-title":"Gut microbiota and predicted metabolic pathways in a sample of Mexican women affected by obesity and obesity plus metabolic syndrome.","volume":"20","author":"Ch\u00e1vez-Carbajal","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B78","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3920\/BM2016.0184","article-title":"Gut microbiota dysbiosis associated with glucose metabolism disorders and the metabolic syndrome in older adults.","volume":"8","author":"Lippert","year":"2017","journal-title":"Benef Microbes."},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/J.CTIM.2021.102699","article-title":"The effect of cinnamon supplementation on liver enzymes in adults: a systematic review and meta-analysis of randomized controlled trials.","volume":"58","author":"Shekarchizadeh-Esfahani","year":"2021","journal-title":"Complement Ther Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1934578X20918687","article-title":"Nutraceutical improves glycemic control, insulin sensitivity, and oxidative stress in hyperglycemic subjects: a randomized, double-blind, placebo-controlled clinical trial.","volume":"15","author":"Bumrungpert","year":"2020","journal-title":"Nat Prod Commun."},{"key":"B81","first-page":"1857","article-title":"Effects of cinnamon aqueous extract on blood glucose level, liver biomarker enzymes, hematological and lipid profile parameters in alloxan-induced diabetic male albino rats.","volume":"1","author":"Longe","year":"2015","journal-title":"Eur Sci J."},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.15171\/APB.2018.065","article-title":"Effects of prebiotic and synbiotic supplementation on glycaemia and lipid profile in type 2 diabetes: a meta-analysis of randomized controlled trials.","volume":"8","author":"Mahboobi","year":"2018","journal-title":"Adv Pharm Bull."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3390\/NU11030635","article-title":"The role of probiotics and prebiotics in the prevention and treatment of obesity.","volume":"11","author":"Cerd\u00f3","year":"2019","journal-title":"Nutrients."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1186\/S12902-018-0248-0","article-title":"The effects of synbiotic supplementation on hormonal status, biomarkers of inflammation and oxidative stress in subjects with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.","volume":"18","author":"Nasri","year":"2018","journal-title":"BMC Endocr Disord."},{"key":"B85","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1017\/S0007114521003780","article-title":"The effect of probiotics\/synbiotics supplementation on renal and liver biomarkers in patients with type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials.","author":"Abdollahi","year":"2022","journal-title":"Br J Nutr."},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3390\/FOODS8030092","article-title":"Prebiotics: definition, types, sources, mechanisms, and clinical applications.","volume":"8","author":"Davani-Davari","year":"2019","journal-title":"Foods."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19031208","article-title":"Awareness, knowledge, and interest about prebiotics-a study among romanian consumers.","volume":"19","author":"Precup","year":"2022","journal-title":"Int J Environ Res Public Health."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.1052619\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T01:55:44Z","timestamp":1669859744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.1052619\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":87,"alternative-id":["10.3389\/fnut.2022.1052619"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2022.1052619","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"article-number":"1052619"}}